Cargando…

Risk Stratification of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy: An Institutional Analysis

BACKGROUND: The purpose of this study was to determine which factors predicted survival and to derive a risk prediction model for patients with locally advanced non-small cell lung cancer (NSCLC) receiving concurrent chemo-radiotherapy (cCRT). METHODS: This investigation included 149 patients with l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sher, Amna, Medavaram, Sowmini, Nemesure, Barbara, Clouston, Sean, Keresztes, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429102/ https://www.ncbi.nlm.nih.gov/pubmed/32848470 http://dx.doi.org/10.2147/CMAR.S250868

Ejemplares similares

Emerging therapies in advanced hepatocellular carcinoma
por: Medavaram, Sowmini, et al.
Publicado: (2018)

Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities
por: Bilfinger, Thomas, et al.
Publicado: (2016)

Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
por: Borghetti, Paolo, et al.
Publicado: (2022)

Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy
por: Lorena, Bottarelli, et al.
Publicado: (2018)

The institutional experience of the implementing 4DCT in NSCLC radiotherapy planning
por: Dang, Huy Quang, et al.
Publicado: (2023)

High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
por: Grambozov, Brane, et al.
Publicado: (2022)

Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
por: Alvarado-Miranda, Alberto, et al.
Publicado: (2009)

Voice outcomes in patients with advanced laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy
por: Álvarez-Marcos, César, et al.
Publicado: (2022)

Small cell carcinoma of the pyriform sinus successfully treated with concurrent chemo-radiotherapy: A case report
por: Lee, Joon Hyung, et al.
Publicado: (2016)

Adjuvant chemo-radiation for gastric adenocarcinoma: an institutional experience
por: Aftimos, Philippe G, et al.
Publicado: (2010)

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
por: Baumann, Brian C., et al.
Publicado: (2020)

Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?
por: Moliner, L., et al.
Publicado: (2023)

Lateral Lymph Node Metastases in Locally Advanced Low Rectal Cancers May Not Be Treated Effectively With Neoadjuvant (Chemo)Radiotherapy Only
por: Haanappel, Anouck, et al.
Publicado: (2019)

Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma
por: Maximous, Doaa W, et al.
Publicado: (2009)

PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy
por: Sistonen, Heli J., et al.
Publicado: (2023)

Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy
por: Safdie, Fernando, et al.
Publicado: (2012)

Tracheo-parenchymal fistula following concurrent chemo-radiation for stage III NSCLC
por: Alzghoul, Bashar, et al.
Publicado: (2016)

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
por: De Giglio, Andrea, et al.
Publicado: (2022)

Post-operative radiotherapy in NSCLC.
por: Stewart, L., et al.
Publicado: (1997)

No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy
por: Walker, Alexandra K, et al.
Publicado: (2018)

No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy
por: Walker, Alexandra K, et al.
Publicado: (2017)

Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2018)

Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
por: Castelli, Barbara, et al.
Publicado: (2023)

Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
por: Wen, Shu Wen, et al.
Publicado: (2015)

Genetic determinants for chemo- and radiotherapy resistance in bladder cancer
por: Mari, Andrea, et al.
Publicado: (2017)

Chemo-/immuno-/radiotherapy combination in treatment of solid cancer
por: Käsmann, Lukas, et al.
Publicado: (2019)

Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
por: Zhao, Mengjing, et al.
Publicado: (2021)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
por: Pellini, Bruna, et al.
Publicado: (2023)

Early post-surgical recurrence of metastatic vertebral neuro-endocrine tumour treated effectively with chemo-radiotherapy
por: Kaliya-Perumal, Arun-Kumar, et al.
Publicado: (2019)

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2022)

A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
por: Lara-Velazquez, Montserrat, et al.
Publicado: (2021)

Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer
por: Olszyna-Serementa, Marta, et al.
Publicado: (2023)

Primary chondrosarcomas of the larynx treated with proton radiotherapy: A single institutional experience
por: Mahase, Sean S., et al.
Publicado: (2022)

1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT
por: Albano, Denise, et al.
Publicado: (2018)

Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
por: Yuan, Shuanghu Tiger, et al.
Publicado: (2014)

Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma
por: Lee, Jen Y, et al.
Publicado: (2017)

Planned neck dissection following chemo-radiotherapy in advanced HNSCC
por: Gupta, Tejpal, et al.
Publicado: (2004)

LncRNA H19 Impairs Chemo and Radiotherapy in Tumorigenesis
por: Garcia-Padilla, Carlos, et al.
Publicado: (2022)

A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma()
por: Gundog, Mete, et al.
Publicado: (2019)

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL(CO) Correlate with Radiation Dosimetry and Pneumonitis Rate
por: Stana, Markus, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rn7d2slspv81og8roq6sinrift